Biotechnology · Healthcare
CFO, Board Member
Since 2017-01-01, last confirmed 2020-04-23
Robert Hoffman
Equibles does not estimate personal net worth.
About Robert Hoffman
Robert Hoffman was last confirmed as CFO and Board Member at Heron Therapeutics, Inc. (HRTX) in a filing dated April 23, 2020. TuHURA Biosciences, Inc. reported in an 8-K filed October 21, 2024 that Robert Hoffman resigned as Interim Chief Financial Officer. TuHURA Biosciences, Inc. reported in an 8-K filed October 21, 2024 that Robert Hoffman resigned as President, Chief Executive Officer. TuHURA Biosciences, Inc. reported in an 8-K filed October 21, 2024 that Robert Hoffman resigned as President, Chief Executive Officer, Interim Chief Financial Officer and Principal Executive Officer and Principal Financial and, effective October 18, 2024. The proxy statement of Heron Therapeutics, Inc. reports total compensation of $1,028,296 for Robert Hoffman in fiscal 2020, including a base salary of $360,009. Disclosed compensation is on record for 4 fiscal years.
“Immediately prior to the Merger, Robert Hoffman resigned from all of his offices with Kintara and all of its subsidiaries, if applicable, including President, Chief Executive Officer, Interim Chief Financial Officer and Principal Executive Officer and Principal Financial and Accounting Officer of Kintara.”
“Immediately prior to the Merger, Robert Hoffman resigned from all of his offices with Kintara and all of its subsidiaries, if applicable, including President, Chief Executive Officer, Interim Chief Financial Officer and Principal Executive Officer and Principal Financial and Accounting Officer of Kintara.”
Affiliation history
-
2017-01-01–2020-04-23
Last confirmed by a filing; no departure on record
-
Start not stated–2020-04-23
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Heron Therapeutics, Inc. (HRTX) | Former Chief Financial Officer and Senior Vice President, Finance | $360,009 | $1,028,296 |
| 2019 | Heron Therapeutics, Inc. (HRTX) | Former Chief Financial Officer and Senior Vice President, Finance | $388,714 | $2,034,232 |
| 2018 | Heron Therapeutics, Inc. (HRTX) | Former Chief Financial Officer and Senior Vice President, Finance | $357,438 | $1,719,634 |
| 2017 | Heron Therapeutics, Inc. (HRTX) | Chief Financial Officer and Senior Vice President, Finance | $235,577 | $2,279,844 |